Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03081494
Title Phase Ib Study of PDR001 in Combination With Regorafenib in Adult Patients With Previously Treated Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | ITA | ISR | ESP | CAN | AUS

Facility Status City State Zip Country Details
Novartis Investigative Site St Leonards New South Wales 2065 Australia Details
Novartis Investigative Site Murdoch Western Australia 6150 Australia Details
Novartis Investigative Site Montreal Quebec H3T 1E2 Canada Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Milano MI 20162 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Seoul Korea 05505 Korea, Republic of Details
Novartis Investigative Site Leiden 2333 ZA Netherlands Details
Novartis Investigative Site Singapore 169610 Singapore Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field